CN
93-97-0
应用筛选条件
关键词:'93-97-0'
显示 1-30 共 168 条结果 关于 "93-97-0" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
99 94 93 111 95 75 100 85 2 0 86 98 138 93 108 102 84 88 104
SAPK2b/p38β2 97 107 97 127 98 90 119 95 10 3 74 98 150 88 96 104 97 92 115
Poster: Purification with Millipore MultiScreen 384SEQ Plates on Beckman-Coulter’s Biomek FX for High Quality Direct Sequencing in High-Throughput Genomics
365.39 93%
il12a_1 zq 39.78 400.66 98% il12a_1 zq 41.14 383.16 88% il12a_1 zq 44.93 452.26 98%
il12a_7-A yq r1 15.65 0 0% il12a_7-A yq r1 0 0 0% il12a_7-A yq r1 40.95 411.51 97%
il12a_7-A yq r2 0 0 0% il12a
The Effective Use of Protein Kinase Inhibitors
99 94 93 111 95 75 100 85 2 0 86 98 138 93 108 102 84 88 104
SAPK2b/p38β2 97 107 97 127 98 90 119 95 10 3 74 98 150 88 96 104 97 92 115
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
)
C
n
15
8.
93
16
2.
50
16
4.
93
(2
47
Lab Notebook Guidelines
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
)
C
n
15
8.
93
16
2.
50
16
4.
93
(2
47
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
)
C
n
15
8.
93
16
2.
50
16
4.
93
(2
47
LABORATORY NOTEBOOK ISSUANCE PAGE
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
)
C
n
15
8.
93
16
2.
50
16
4.
93
(2
47
DOZN SCALE
potatoes—hydrolyzes starch into sugar
Percentage of Improvement
198%
93%
100%
100%
96%
95%
N/A
N/A
N/A
N/A
No Change
97%
96%
57
Amicon® Ultra-2 Centrifugal Filter Devices for volumes up to 2 mL
92
80
61
44
43
41
78
75
78
93
86
67
27
22
25
1159
10
20
48
96
97
97
98
93
82
35
39
37
Product Information Sheet - Amine-Stabilized Borane-Tetrahydrofuran Solutions
Isolated Yield (%) Regioselectivity (1:2)
17,619-2 NaBH
4
96 92 94:6
65,039-0 PMP 94 90 93:7
65,041-2 NIMBA 97 93 94:6
AL-211 AtmosBag™ - Inflatable Polyethylene Isolation ChambersAL-218
Amicon® Ultra-2 Centrifugal Filter Devices User Guide
92
80
61
44
43
41
78
75
78
93
86
67
27
22
25
1159
10
20
48
96
97
97
98
93
82
35
39
37
High throughput sample preparation for the quantitation of drug compounds in serum samples
Digoxin 93±3% 96±2% 98±3% 94±1%
Propranolol 97±2% 98±4% 95±3% 96±2%
Taxol 93±3% 92±1% 91±2% 88±2%
Testosterone 94±3% 92±2% 91±2% 90±1%
Verapamil 95±3% 97±1% 92±2% 98±1%
Warfarin 91±3% 93±2% 90±
Verfication summary-03-0202-00
2% 128.61 0.1 0% 114%
2822620
3 MRD (1:2) 65.30 1.4 2% 130.59 1.4 1% -
3 1:4 31.75 1.1 4% 126.99 1.1 1% 97%
3 1:8 16.42 1.2 7% 131.38 1.2 1% 101%
3 1:16
Verfication summary-03-0202-00
2% 128.61 0.1 0% 114%
2822620
3 MRD (1:2) 65.30 1.4 2% 130.59 1.4 1% -
3 1:4 31.75 1.1 4% 126.99 1.1 1% 97%
3 1:8 16.42 1.2 7% 131.38 1.2 1% 101%
3 1:16
MultiScreen Ultracel®-10 filter plate: Nucleic Acid Applications
concentration
- 301 bp
100 uL 300 uL 100 uL 300 uL
137 bp 90 82 84 97
301 bp 96 90 90 89
657 bp 97 93 91 94
1159 bp 100 93 92 94
Percent
The HydroCorr Integrity Test
Fax (65) 254 4056
SPAIN
Madrid:
Tel. (91) 729 03 00
Fax (91) 729 29 09
Barcelona:
Tel. (93) 451 70 00
Fax (93) 451 60 48
SWEDEN
Tel. 08-628 69 60
Fax 08-628 64 57
SWITZERLAND
Tel. (01) 908-30-60
Impurities & Related Compounds: Reference Materials
PHR8955-50MG
446-86-6
4531-54-8
79307-93-0
53242-88-9
20526-97-0
117772-70-0
90503-06-3
612069-28-0
1134-47-0
22518-27-0
86541-74-4
215447-89-5
86541-77-7
88372
Application Note – N-Boc deprotection
NH
98%
F
Cl
O
N
H
93%
N
H
N
Cbz
97%
N
H
N
OH
95%
HO
NH2
95%
HO
O
NH2
92%
TsOH TsOH
TsOH
Product Information Sheet - M7888
Natl. Acad. Sci. USA, 93(8), 3346-3351 (1996).
6. Saez, E., et al., Identification of ligands and
coligands for the ecdysone-regulated gene switch.
Proc. Natl. Acad. Sci. USA, 97(26), 14512-14517
(
Protocol
Serum 1 0 0
4.7 4.4 94
9.4 9.0 96
18.8 17.7 95
Serum 2 0 0.0
4.7
Product Information Sheet - A1774
amikacin by liquid
chromatography with pulsed electrochemical
detection. J. Chromatogr. A, 819(1-2), 93-97
(1998).
7. Oguri, S., and Miki, Y., Determination of amikacin
in human plasma by high-performance
MAK415 - Technical Bulletin
well)
1 0 L 95 L 0
2 2 L 93 L 4
3 4 L 91 L 8
4 6 L 89 L 12
5 8 L 87 L 16
6 10 L 85 L 20
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
et al., Br. J. Pharmacol., 97, 783-794 (1989).
91. Ogletree, M.L., et al., J. Pharmacol. Exp. Ther., 234, 435-441 (1985).
92. Hall, S.E., Med. Res. Rev., 11, 503-579 (1991).
93. Ogletree, M.L., et al., J
Data Sheet - K0140
developed in
rabbit using a synthetic peptide (C)RSRKVDKRSDPYH,
corresponding to amino acid residues 81-93 of human
KCNE3 (Gene ID 10008). This epitope is identical in
rat, mouse, dog and pig. The antibody
Product Information Sheet - MAK494
Purified
Water
Creatine
(µM)
1 10 µL 90 µL 50
2 6 µL 94 µL 30
3 3 µL 97 µL 15
4 0 µL 100
Product Information Sheet - M3633
human fibroblasts from
controls and patients with Gaucher's disease. Clin.
Chim. Acta., 49(1), 93-97 (1973).
8. Ockerman, P. A., and Kohlin, P., Tissue acid
hydrolase activities in Gaucher's
Product Information Sheet-04693116001
0.0015 7.8 88 99
0.003 7.0 90 95
Thermolysin 0.0008 7.8 99 100
Chymotrypsin 0.0015 7.8 97 97
Trypsin 0.0002 7.8 93 89
Papain 1.0 6.5 95 73
The inhibitory power of cOmplete has been demonstrated with
Protocol: Human Ghrelin (Active)
µL 33 95% 21 93%
3
20 µL 438 100% 393 100%
10 µL 226 103% 192
Product Information Sheet-co-ro
0.0015 7.8 88 99
0.003 7.0 90 95
Thermolysin 0.0008 7.8 99 100
Chymotrypsin 0.0015 7.8 97 97
Trypsin 0.0002 7.8 93 89
Papain 1.0 6.5 95 73
The inhibitory power of cOmplete has been demonstrated with
Product Information Sheet - I1884
2. Ham, R.G., and McKeehan, W.L., Media and
growth requirements. Methods in Enzymology, 58,
44-93 (1979).
3. Hinman, J.W., Prostaglandins. Ann. Rev. Biochem.,
41, 161-178 (1972).
4. Kano-Sueoka
1/6